Taiwan to start importing Pfiser COVID-19 antiviral pills by March

17-Jan-2022 Intellasia | TaiwanNews | 7:32 AM Print This Post

The first batch of 10,000 COVID-19 oral antiviral pills made by Pfiser will arrive in Taiwan by March, reports said Saturday (January 15).

Taiwan and Pfiser signed a contract for the medicine, known as Paxlovid, on Friday (January 14), according to a report by CNA. The company said the drug could reduce the risk of hospitalisation or death by as much as 89%.

Taiwan’s Food and Drug Administration (FDA) reportedly held a meeting with experts Saturday morning to discuss the emergency use authorisation (EUA) for the pill.

A total of 10,000 doses of an earlier antiviral pill, Molnupiravir, were expected to arrive in the country after the Lunar New Year holiday after the EUA was approved on January 8. The supply contract was signed last year with its developers, Merck, Sharp, and Dohme and Ridgeback Biotherapeutics of the United States.

Recent comments by the Central Epidemic Command centre (CECC) indicated that the talks with Pfiser about its oral antiviral drug had reached their final stage.



Category: Taiwan

Print This Post

Comments are closed.